Magnitude, Associated Risk Factors, and Trend Comparisons of Urinary Tract Infection among Pregnant Women and Diabetic Patients: A Systematic Review and Meta-Analysis

Girma, Abayeneh; Aemiro, Aleka; Workineh, Dereba; Tamir, Dessalew

doi:https://doi.org/10.1155/2023/8365867

Journal of Pregnancy

On this page

Abstract Introduction Methods Results Discussion Conclusion Abbreviations Data Availability Conflicts of Interest Authors’ Contributions Supplementary Materials References Copyright Related Articles

Review Article | Open Access

Volume 2023 | Article ID 8365867 | https://doi.org/10.1155/2023/8365867

Magnitude, Associated Risk Factors, and Trend Comparisons of Urinary Tract Infection among Pregnant Women and Diabetic Patients: A Systematic Review and Meta-Analysis

Abayeneh Girma,¹Aleka Aemiro,¹Dereba Workineh,²and Dessalew Tamir³

Academic Editor: A.Seval Ozgu-Erdinc

Received05 May 2022

Revised12 Jan 2023

Accepted19 May 2023

Published28 Jul 2023

Abstract

Urinary tract infection (UTI) remains the most common bacterial infection that affects millions of people around the world, especially pregnant women (PW) and people with diabetes mellitus (DM). This systematic review and meta-analysis was aimed at finding the pooled prevalence of UTI and its associated risk factors among PW and DM patients. Scientific articles written in English were recovered from PubMed, ScienceDirect, Web of Science, Google Scholar, Cochrane Library, Google Engine, and University Library Databases. “Prevalence,” “urinary tract infection,” “associated factors,” “pregnant women,” “diabetic patients,” and “Ethiopia” were search terms used for this study. For critical appraisal, PRISMA-2009 was applied. Heterogeneity and publication bias were evaluated using Cochran’s , inverse variance (), and funnel plot asymmetry tests. A random effect model was used to calculate the pooled prevalence of UTI and its associated factors among both patients, along with the parallel odds ratio (OR) and 95% confidence interval (CI). For this meta-analysis, a total of 7271 participants were included in the 25 eligible studies. The pooled prevalence of UTI in Ethiopia among both patients was 14.50% (95% CI: 13.02, 15.97), of which 14.21% (95% CI: 12.18, 16.25) and 14.75% (95% CI: 12.58, 16.92) were cases of DM and PW, respectively. According to the subgroup analysis, the highest prevalence was observed in the Oromia region (19.84%) and in studies conducted from 2018 to 2022 (14.68%). Being female (AOR: 0.88, and 95% CI: 0.11, 1.65, ) and having an income (AOR: 4.46, and 95% CI: -1.19, 10.12, ) were risk factors significantly associated with UTI among patients with DM and PW, respectively. Furthermore, a history of catheterization ( and 95% CI: 1.35, 9.81, ), urinary tract infection (AOR: 3.52, and 95% CI: 1.96, 5.08, ), and symptomatic patients (AOR: 2.32, and 95% CI: 0.57, 4.06, ) were significantly associated with UTI in both patients. Early diagnosis and appropriate medication are necessary for the treatment of UTI in patients with DM and PW.

1. Introduction

Urinary tract infection (UTI) is defined as the colonisation of a pathogen in any part of the urinary tract, including the kidney, ureter, bladder, and urethra. Infection of the urinary tract is one of the most common infectious diseases, affecting people of all ages and causing about 150 million global cases per year, in addition to costing the global economy over $6 billion in treatment costs [1, 2]. UTIs are classified according to their location of infection (pyelonephritis (kidney), cystitis (bladder), and urethritis (urethra)) as well as their severity (complicated versus uncomplicated) [3]. Uncomplicated UTIs affect people who are otherwise healthy and do not have anatomical or neurological problems with their urinary system. These infections are classified as lower UTIs (cystitis) or higher UTIs (urethritis) or pyelonephritis. Cystitis can be caused by a number of factors, including current symptoms of UTI, a history of UTI and catheterisation, sexual activity, vaginal infection, diabetes, obesity, and genetic predisposition [4]. Complicated UTIs are those that are linked to factors that influence the urinary tract or the host’s immune system. Urinary blockage, urine retention owing to neurological disease, immunosuppression, renal failure, renal transplantation, pregnancy, and the presence of foreign substances such as calculi, indwelling catheters, or other drainage devices are all potential complications of UTIs [5].

Diabetes mellitus (DM) is one of the most common noncommunicable diseases, affecting the health of a large proportion of the global population. The presence of fasting blood glucose levels greater than 126 mg/dL is a key symptom of diabetes mellitus [6]. Globally, the prevalence is expected to increase from 171 million in 2000 to 366 million by 2030 [7]. The frequency of diabetes mellitus is rising across Africa, and the disease’s severity is worsening [8]. More than 12 million people in sub-Saharan Africa are predicted to have diabetes mellitus, with 330,000 of them dying from its complications [9]. According to WHO estimates, the number of diabetic cases in Ethiopia was 800,000 in 2000, and this figure is expected to increase to 1.8 million by 2030 [10]. Although diabetes mellitus is considered one of the most serious noncommunicable illnesses in Ethiopia, its exact prevalence, progression, and complications are not adequately documented or updated on a regular basis.

Urinary tract infections are associated with considerable morbidity in both the mother and the baby during pregnancy. The combination of mechanical, hormonal, and physiological changes that occur during pregnancy causes significant changes in the urinary system that have a considerable impact on the acquisition of bacteriuria and its natural history [11]. Infections of the urinary tract during pregnancy can result in poor pregnancy outcomes and complications such as preterm delivery, low birth weight, preeclampsia (toxaemia), and anaemia. Therefore, it is important to check and treated as soon as possible. Prenatal screening is not considered a necessary aspect of antenatal care in most impoverished countries, including Ethiopia [12].

The identification of the types of organisms that cause urinary tract infections in diabetes mellitus (DM) and pregnant women (PW) patients, as well as the selection of an effective antibiotic against the organism in question, is critical to the successful care of these individuals. The rise of resistant bacterial strains in hospitals continues to represent a problem in terms of the treatment and control of disease transmission. Furthermore, the indiscriminate use of antibiotics often leads to an increase in resistant urinary pathogens to the most commonly used antimicrobial medications, especially in patients with diabetes and pregnant women. Although UTIs rarely cause complications, they can have serious consequences in terms of morbidity and mortality [13]. According to various studies, the prevalence of UTI is increasing in Ethiopia. In a few hospital-based studies conducted in Ethiopia’s central and northwest regions, rates of antibiotic resistance in urinary tract infections ranged from 10.4% to 17.8%, with a greater rate of multidrug resistance in diabetic patients ranging from 59.8% to 71.7 percent [14]. In Ethiopia, the prevalence of urinary tract infections (UTIs) among pregnant women varies greatly; it ranges from 9.8% to 26.6% [15]. In addition, the isolates were found to have a significant level of resistance to routinely used antibiotics, leaving clinicians with a limited number of options for treating UTIs.

Sex, illiteracy, history of catheterization, blood glucose level, type of diabetes, duration of DM, insulin therapy, cigarette smoking, and history of UTI have been identified as important risk factors for UTI among diabetes patients [16], while sociodemographic factors such as maternal age, residence, marital status, maternal educational status, monthly family income, and maternal occupation, as well as medical and obstetric-related factors such as anaemia, HIV status, history of UTI, history of catheterization, parity, and gestational age, have been identified as potential-associated factors for UTI in pregnant women [15, 17].

Urinary tract infections are one of the most common public health problems, with varying levels of prevalence throughout the country. Even in Ethiopia, the prevalence of UTI and its predisposing factors are not well collected, organised, or recorded as a systematic review and meta-analysis. As a result, the objective of this study was to provide evidence on the general prevalence and risk factors for UTIs among patients with DM and PW using previously conducted research articles. Furthermore, the results obtained in the current investigation could significantly benefit healthcare providers, users, and policymakers.

2. Methods

2.1. Country Profile

Ethiopia measures 1,104,300 square kilometers and is located in the Horn of Africa. The total land area is 1,000,000 square kilometers (386,102 square miles). Ethiopia is bordered to the north by Eritrea, to the east by Djibouti and Somalia, to the west by Sudan and South Sudan, and to the south by Kenya. According to Worldometer’s elaboration of the most recent United Nations data, Ethiopia’s current population was 113,881,451 in 2020, which is comparable to 1.47 percent. Furthermore, the aforementioned report predicts that by 2020, approximately 21.3% of the population (24,463,423) will live in urban areas [18, 19].

2.2. Search Strategy

This systematic review and meta-analysis were performed according to the guidelines for preferred reporting items for systematic review and meta-analysis (PRISMA) [20]. An extensive search was conducted in international databases (PubMed, ScienceDirect, Web of Science, Google Scholar, and the Cochrane Library) and other sources (Google Engine and University Library Databases). Journals were searched using key terms and phrases such as “prevalence,” “urinary tract infection,” “pregnant women,” “diabetic patients,” “associated risk factors,” and “Ethiopia”. The study was conducted from November 2021 to June 2022. The search process was presented as per PRISMA-2009 flow chart guidelines that clearly indicate the studies included and excluded, along with reasons for exclusion (Figure 1).

2.3. Criteria for the Inclusion and Exclusion of Studies

In this systematic and meta-analytic review, institutional, hospital, and community-based studies were included. Articles collected through the searches were evaluated for inclusion in the meta-analysis based on the following criteria: (i) Ethiopian studies on the prevalence of UTI and their risk factors with at least 160 observations; (ii) only human studies reported in English with clearly stated sample sizes, number of positive samples, and study locations; (iii) cross-sectional studies; (iv) journals studied from 2012 to 2022; (v) articles published and available online; (vi) articles used the culture method for the detection of UTI; (vii) reported both asymptomatic and symptomatic UTIs; and (viii) only studies reported bacterial etiological agents. However, reports on the knowledge and practise of diabetic patients or pregnant women towards UTI, investigate patterns of antimicrobial resistance only, only asymptomatic studies, other etiological agents (fungal and protozoan), duplicate publications or extensions of the analysis of the original studies, and studies that were incompletely presented were excluded from the review process. Among many of the previously published articles, only 25 met the selection criteria of the meta-analysis (Figure 1).

2.4. Data Extraction

Microsoft Excel (2010) and STATA version 14 software were used for data extraction and analysis. The data extraction protocol consists of the name of the country, author and year of publication, region, study area, type of UTI patients (pregnant women or diabetics), study setting, study design, sample taken, laboratory method used for detection of UTI, type of UTI (asymptomatic or symptomatic or both), etiological agents (bacterial, fungal, protozoan, or all), sample size, number of positive cases, prevalence of UTIs, quality assessment, and their associated risk factors. If the study was conducted over a range of years, then the latest year of the stated range was used. The period from January 1 to March 30, 2022, was used for study selection, quality evaluation, and data extraction.

2.5. Quality Assessment of Individual Studies

The general quality of the evidence was evaluated using the GRADE approach (recommendations assessment, development, and evaluation) [21]. Using the three main assessment tools (methodological quality, comparability, study outcome, and statistical analysis), the quality of each study was determined. High-quality publications received 5 to 6 points, moderate-quality publications received 4 points, and low-quality articles received 0 to 3 points. The choice and evaluation of the articles’ quality were done independently by four reviewers (A.G., A.A., D.W., and D.T.). The articles were added after the agreement was reached, and discrepancies between the reviewers were resolved through discussion.

2.6. Risk of Publication Bias

Using funnel plot symmetry, Cochran’s test, and the test, the risks of publication bias and heterogeneity were analysed.

2.7. Statistical Analysis

The pooled prevalence of UTIs among patients with DM and PW was calculated by dividing the total number of positive cases by the total number of study subjects included in this meta-analysis and multiplying by a factor of 100. A random effect model was used to estimate the size of the pooled effects. To sort out the causes of heterogeneity, subgroup analysis was conducted based on sample size, region of the study, study setting, type of patients, and the year of publication. The Cochran statistic with inverse variance () and funnel plot symmetry was used to assess the existence of statistical heterogeneity. The Cochran statistic was used to determine whether heterogeneity was present between studies. While the heterogeneity (heterogeneity between studies) was measured using the statistic, values of 25, 50, and 75%, respectively, indicated moderate, medium, and high heterogeneity [22]. A log odds ratio was used to decide the association between UTIs and associated risk factors among respondents included in the studies. Meta-analysis was performed using Stata software version 14, where was considered statistically significant.

3. Results

A total of 378 articles on the prevalence and associated risk factors for UTI among diabetic patients and pregnant women in Ethiopia were retrieved. Of 378 articles, one hundred seventy-two of these articles were excluded due to duplicates. From the remaining 206 articles, 97 were excluded based on specific criteria included in the inclusion criteria and data extraction protocol. Of the remaining 109 articles, 69 were also excluded due to the fact that they did not have OR, 95% CI, or the number of positive cases (which means that the report was based only on the estimated prevalence percentage). Thus, only 40 and 25 of the studies, respectively, met the eligibility criteria and were included in the final systematic review and meta-analysis study (Figure 1).

3.1. Characteristics of the Eligible Studies

Table 1 presents the characteristics of the studies eligible for analysis. Forty and twenty-five studies were eligible for systematic reviews (Table 1) and meta-analyses (Table 2), respectively. The studies included in the meta-analysis were conducted between 2012 and 2022, and all were cross-sectional studies. Six studies had ≤200 sample sizes, while 19 articles had >200 samples. Nine and sixteen studies were conducted between 2012 and 2017 and 2018 and 2022, respectively. Regarding the types of patients, 12 articles were included for patients with diabetes, and 14 were for pregnant women. Based on the criteria, Amhara (9 articles), Oromia (5 articles), eastern (Harari, Dire Dawa, and Somali) Ethiopia (5 articles), Sidama (4 articles), and Addis Ababa (2 articles) were involved. Nineteen, four, and three articles were carried out in hospital, institutional, and facility settings, respectively. The prevalence of DM among eligible studies ranged between 9.8% and 20.2%. Furthermore, the prevalence of UTI among PW ranged from 7.8% to 26.0% (Table 2).

3.2. Pooled Prevalence of UTI

A sensitivity analysis was performed using a random effect model to examine the effects of the individual-included studies on the pooled prevalence of UTI in Ethiopia. The results showed that no single study had an impact on the combined prevalence of UTI among patients with DM and PW. The overall national prevalence of UTI among patients with DM and PW was 14.50 (95% CI: 13.02, 15.97) (Figure 2).

3.3. Subgroup Analysis

A meta-regression was performed to identify heterogeneity sources using sample size, year of publication, and study setting as covariates. However, it was indicated that there are effects on heterogeneity between studies, as indicated by a significant value (Table 3, Figures 3–5). Thus, considerable UTI prevalence was reported as 15.64 (95% CI: 12.82, 18.46) in ≤200 sample sizes compared to the counterparts (>200) 14.15 (95% CI: 12.42, 15.87) (Table 3 and Figure 3). The high pooled prevalence of UTI among DM and PW patients was reported from the Oromia region at 19.84% (95% CI: 16.37, 23.31), followed by eastern Ethiopia at 14.57% (95% CI: 12.98, 16.16), Amhara at 13.91% (95% CI: 11.59, 16.23), and Addis Ababa at 12.20% (95% CI: 7.21, 17.19), whereas the low prevalence of UTI was observed in the Sidama region at 11.57% (95% CI: 8.40, 14.74) (Table 3, Figures 6 and 7). The highest pooled prevalence estimate in the study period was recorded between 2018 and 2022: 14.68% (95% CI: 12.66, 16.71), followed by the study period from 2012 to 2017 with a pooled prevalence estimate of 14.30% (95% CI: 12.33, 16.27) (Table 3 and Figure 4). The high pooled prevalence of UTI was reported in pregnant women at 14.75% (95% CI: 12.58, 16.92), followed by diabetic patients at 14.21% (95% CI: 12.18, 16.25) (Table 3 and Figure 8). In the study setting, the highest pooled prevalence estimate was 17.63% (95% CI: 13.54, 21.72) in the institutional-based studies, followed by facility-based studies at 16.37% (95% CI: 12.79, 19.96), and the least at 13.55% (95% CI: 11.88, 15.23) in hospital-based studies (Table 3 and Figure 5).

3.4. Factors Associated with DM and PW Patients in Ethiopia

In this systematic review and meta-analysis, we have checked several risk factors for their association with UTI among patients with DM and PW in Ethiopia, such as age (both), sex (DM), education level (both), income level (PW), residence (PW), gestational period (PW), hemoglobin level (PW), history of catheterization (both), previous history of UTI (both), current symptoms of UTI (both), blood glucose level (DM), and type of diabetes (DM). However, only sex (DM), income level (PW), previous history of UTI (both) current symptoms of UTI (both), and history of catheterisation (both) were significantly associated with UTI (S1, S2, S3, S4, and S5).

The association between sex and UTI among patients with DM was analysed in six studies (S1). Female DM patients were 0.88 times more likely to have a UTI than male DM patients (95% CI: 0.11, 1.65, ). Furthermore, the pooled result of sex was significantly associated with UTI among DM patients (S1).

The pooled results of four studies (S2) showed that income level was significantly associated with UTI among patients. The odds of having a UTI among the income levels were 4.46 times higher for ≤500 ETB than for the parallel (95% CI: -1.19, 10.12, ).

The association between the previous history of UTI among patients with DM and PW in Ethiopia was calculated from 13 studies (S3). AOR showed that the previous history of UTI among patients with DM and PW was 3.52 (95% CI: 1.96, 5.08, ) times higher than their counterparts.

The association between the current symptoms and UTI in DM and PW patients was computed from six studies (S4). Symptomatic DM and PW patients were 2.32 (95% CI: 0.57, 4.06, ) times higher than their asymptomatic counterparts.

The pooled odds result of six studies (S5) showed that the history of catheterization was significantly associated with UTI in both patients. The AOR of having a UTI among DM and PW patients with a history of catheterization was 5.58 times higher than their counterparts (95% CI: 1.35, 9.81, ).

Twenty-two studies obtained high-quality scores, while three had middle-quality scores when it came to assessing risk bias (Table 1). The most common biases observed were representation and case definition. The pooled prevalence without medium-quality studies was calculated to see how they affected our estimates of pooled prevalence. Our pooled prevalence estimates with and without these studies had confidence intervals that overlapped, indicating that there was no meaningful difference between them (Figure 9). Based on these findings, the majority of the primary study authors met high-quality standards (Figure 9). This gives our findings more credibility.

4. Discussion

Urinary tract infections (UTIs) are among the most common infections that affect people of all ages around the world. The most common bacterial infection in pregnancy is the UTI, and it increases the risk of morbidity and mortality in both the mother and the newborn. When bacteriuria strikes during pregnancy, it results in a much higher number of neonates with low birth weight, early birth, and a higher neonatal mortality rate [62]. UTI coinfection among diabetic patients is also becoming a more common cause of morbidity than in normal individuals. Evidence shows that in developing countries, it is highly linked to low-income economies that bear the brunt of the burden due to a lack of resources to combat diseases before they become severe [63–66]. Furthermore, UTIs are common in pregnant women and diabetics due to immune system dysfunction caused by decreased cell responses [67, 68].

The overall pooled prevalence of UTI among DM and PW patients in the present study was 14.50%. This was relatively comparable to the studies conducted in Nekemte (16.5%) [32], Metu (16.7%) [40], and Gondar (17.8%) [25] and outside of Ethiopia, like Kenya (15.8%) [63], Nigeria (17.3%) [64], and Sudan (19.5%) [65]. The result was higher than the reports in Jimma (9.2%) [66], Addis Ababa (9.8%) [57], and Dessie (11.6%) [50] and outside Ethiopia, like Romania (10.7%) [69], Nepal (10.37%) [70], and Uganda (13.3%) [67]. However, the prevalence was lower than the studies reported in Harar (23.0%) [45], Bahir Dar (30.5%) [68], Arba Minch (33.9%) [41], and Shashemene (90.1%) [71] and studies conducted outside Ethiopia, such as in Uganda (31.1%) [72], Kuwait (35%) [73], Malaysia (40.2%) [16], India (49.15%) [74], Pakistan (52.76%) [75], Egypt (52.2%) [76], and Nepal (54.25%) [77]. The magnitude variation could be due to differences in geographical characteristics, study year, host factor, and practises, such as social habits of the community and standards of personal hygiene and health education practises in each country.

In this study, the overall prevalence of UTI among diabetic patients was 14.21% (95% CI: 12.18, 16.25). This was relatively comparable with the studies conducted in Hawassa (14.70%) [61], Addis Ababa (14.9%) [42], and Harar (15.4%) [33] and outside Ethiopia, such as in Uganda (13.3%) [67], Tanzania (13.7%) [78], and Nigeria (17.3%) [79]. However, this finding is not in accordance with the results reported from Bahir Dar (30.5%) [68] and Arba Minch (33.9%) [41] and outside of Ethiopia, such as India (32%) [80], Iraq (49.1%) [81], Nepal (50.7%) [82], Pakistan (51%) [83], and Egypt (52.2%) [76]. The researchers hypothesised that poor circulation, a weakened immune system caused by a decrease in the capacity of white blood cells to fight infections, and poor bladder contractions that result in dysfunctional bladder function were some of the contributing factors that led to an increase in UTI cases in diabetic patients [84–86].

In this study, the overall prevalence of UTI in pregnant women was 14.75% (95% CI: 12.58, 16.92). This was in agreement with similar studies reported in Ethiopia (14.0%) [28], Sudan (14%) [87], Kenya (14.2%) [88], and Tanzania (14.6%) [89]. But it was higher than the studies conducted in Bahir Dar (9.5%) by Demilie et al. [90], in Gondar (10.4%) by Alemu et al. [23], and in Addis Ababa (11.6%) by Assefa et al. [14]. In contrast, it was lower than studies conducted outside Ethiopia in Libya (30%) [91], Iraq (64.6%) [92], and Nigeria (85%) [93]. This difference may be explained by the fact that the environment, social habits of the community, personal hygiene standards, and educational levels in each nation may differ, which could account for the variation in the rate of bacterial UTI aetiologies.

Regarding regions, the highest pooled prevalence estimate of UTI among patients with PW and DM was 19.84% in the Oromia region. This was relatively consistent with the studies conducted in Harar (19.9%) [46] and Gondar (17.8%) [25]. On the other hand, the result was relatively lower than the findings conducted in Arba Minch (33.9%) [41] and Bahir Dar (30.5%) [68] and outside of Ethiopia, in Uganda (31.1%) [72], India (32%) [80], and Kuwait (35%) [73]. While the result was greater than the studies reported from Bahir Dar (9.5%) [26], Addis Ababa (9.8%) [57], Mizan Aman (10.3%) [44], and Dessie (11.6%) [50], this variation could be due to the difference in study year, sample size, patient type (symptomatic or asymptomatic or both), type of identification method used, type of etiological agents studied (bacterial, fungal, protozoan, or all), and study setting (geographical variations).

In this study, the magnitude of UTIs was 0.88 times (95% CI: 0.11, 1.65) more likely to develop in female diabetics than male diabetics, which is in agreement with previously reported studies in Ethiopia [86, 94], Romania [95], Saudi Arabia [96], the United States of America [97], and India [98]. The high prevalence of UTI among the female population might be due to their anatomy and reproductive physiology, such as the decrease of normal vaginal flora (Lactobacilli), the less acidic pH of the vaginal surface, poor hygienic conditions, a short and wide urethra, proximity to the anus, and sexual intercourse, which may force bacteria into the female bladder.

With regard to income level, pregnant women with a family income of less than or equal to 500 ETB were more likely to acquire UTI (AOR: 4.46; 95% CI: -1.19, 10.12) than their counterparts. This result is consistent with the findings conducted in Ethiopia [26], Egypt [99], and Pakistan [100]. This may be demonstrated by the fact that pregnant women with poor socioeconomic status were more likely to be exposed to malnutrition, which had an impact on immunity.

Furthermore, the pooled odds ratio showed that DM and PW patients who had a previous history of UTI were 3.52 times (95% CI: 1.96, 5.08) more likely to acquire UTI than their counterparts. This finding is in parallel with previous findings conducted in the country [31, 86] as well as in other parts of the world [100, 101]. Furthermore, patients with current symptoms of UTI (symptomatic patients) were 2.32 times more likely to develop UTI than asymptomatic patients. The difference could be due to the return of the infection as a result of inadequate therapy and the presence of high sugar concentrations in diabetic urine, which act as a medium for pathogenic bacteria to multiply, or recollection bias.

Regarding catheterization, the odds of a person having a history of catheterization were 5.58 times (95% CI: 1.35, 9.81, ) more likely to catch a UTI than a person without a previous history of catheterization. This result is in line with the study conducted in Ethiopia [15] and elsewhere [100, 102]. The intrusive procedure of catheterization has the potential to harm the urethral mucosa. Additionally, due to ineffective infection control or inadequate aseptic technique, it may result in the introduction of a bacterial organism that causes haematogenous bacterial dissemination and recurrent UTIs [103].

4.1. Limitations of the Study

Small numbers of published papers were collected from the regions involved in this study, and published papers from the Afar, B/Gumuz, SNNPR, and Gambela regions were not included, so the prevalence of UTI and associated risk factors among DM and PW patients may not be fully represented.

5. Conclusion and Recommendations

Urinary tract infections and other noncommunicable diseases are becoming more prevalent in developing countries like Ethiopia due to a lack of problem identification, effective treatment, and intervention measures. The overall pooled prevalence of UTI among both DM and PW patients was 14.50%. Being female and having a family income ETB had a higher risk of acquiring UTI among DM and PW patients, respectively. Furthermore, patients with a previous history of UTI, catheterization, or symptomatic patients had higher odds of contracting UTI than those who had no previous history of UTI, catheterization, or asymptomatic patients. Increasing the community’s knowledge about frequent urine analysis and antenatal care services, blood sugar tests, early diagnosis, and proper medications should be addressed to alleviate the prevalence of UTI in patients with DM and PW.

Abbreviations

AOR:	Adjusted odds ratio
CI:	Confidence interval
DM:	Diabetes mellitus
ETB:	Ethiopian birr
GRADE:	Grading of recommendations assessment, development, and evaluation
PRISMA:	Preferred reporting items for systematic reviews and meta-analyses
PW:	Pregnant women
SNNPR:	South nations nationality people region
STATA:	Statistical software for data science
UTI:	Urinary tract infection.

Data Availability

The data generated and analysed during this study are included in this article.

Conflicts of Interest

The authors declare that they have no conflicts of interest regarding the publication of this study.

Authors’ Contributions

A. G., A.A., D.W., and D.T. designed the project, selected the articles, extracted data, and were actively involved in statistical analysis. A.A., D.W., and D.T. were involved in developing the initial drafts of the manuscript. A. G. edited the overall language. All authors have read and approved the final manuscript.

Supplementary Materials

Supplementary Materials S1: sex as an associated risk factor for UTI among patients with DM. S2: income level as an associated risk factor for UTI among PW patients. S3: previous history of UTI as an associated risk factor for UTI among DM and PW patients. S4: current symptoms of UTI as an associated risk factor for UTI among DM and PW patients. S5: history of catheterization as an associated risk factor for UTI among DM and PW patients. (Supplementary Materials)

References

K. Iregbu and P. Nwajiobi-Princewill, “Urinary tract infections in a tertiary hospital in Abuja, Nigeria,” African Journal of Clinical and Experimental Microbiology, vol. 14, no. 3, pp. 169–173, 2013.
View at: Publisher Site | Google Scholar
A. Girma and A. Aemiro, “The bacterial profile and antimicrobial susceptibility patterns of urinary tract infection patients at Pawe General Hospital, northwest Ethiopia,” Scientifica, vol. 2022, Article ID 3085950, 8 pages, 2022.
View at: Publisher Site | Google Scholar
S. L. Chang and L. D. Shortliffe, “Pediatric urinary tract infections,” Pediatric Clinics, vol. 53, no. 3, pp. 379–400, 2006.
View at: Publisher Site | Google Scholar
T. M. Hooton, “Uncomplicated urinary tract infection,” New England Journal of Medicine, vol. 366, no. 11, pp. 1028–1037, 2012.
View at: Publisher Site | Google Scholar
P. Lichtenberger and T. M. Hooton, “Complicated urinary tract infections,” Current Infectious Disease Reports, vol. 10, no. 6, pp. 499–504, 2008.
View at: Publisher Site | Google Scholar
M. S. Perzanowski, L. W. Ng'ang'a, M. C. Carter et al., “Atopy, asthma, and antibodies to _Ascaris_ among rural and urban children in Kenya,” The Journal of Pediatrics, vol. 140, no. 5, pp. 582–588, 2002.
View at: Publisher Site | Google Scholar
S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global prevalence of diabetes,” Diabetes Care, vol. 27, no. 5, pp. 1047–1053, 2004.
View at: Publisher Site | Google Scholar
G. Gill, J.-C. Mbanya, K. Ramaiya, and S. Tesfaye, “A sub-Saharan African perspective of diabetes,” Diabetologia, vol. 52, no. 1, pp. 8–16, 2009.
View at: Publisher Site | Google Scholar
A. Motala and K. Ramaiya, “Diabetes: the hidden pandemic and its impact on sub-Saharan Africa,” Diabetes Leadership Forum, Johannesburg ed., South Africa, 2010, https://www.comminit.com/africa/content/diabetes-hidden-pandemic-and-its-impact-sub-saharan-africa.
View at: Google Scholar
A. F. Amos, D. J. McCarty, and P. Zimmet, “The rising global burden of diabetes and its complications: estimates and projections to the year 2010,” Diabetic Medicine, vol. 14, no. S5, pp. S7–S85, 1997.
View at: Publisher Site | Google Scholar
M. T. Aseel, F. M. Al-Meer, M. G. Al-Kuwari, and M. F. S. Ismail, “Prevalence and predictors of asymptomatic bacteriuria among pregnant women attending primary health care in Qatar,” World Family Medicine, vol. 7, no. 4, pp. 10–13, 2009.
View at: Google Scholar
R. Colgan, L. E. Nicolle, A. McGlone, and T. M. Hooton, “Asymptomatic bacteriuria in adults,” American Family Physician, vol. 74, no. 6, pp. 985–990, 2006.
View at: Google Scholar
A. Ronald and E. Ludwig, “Urinary tract infections in adults with diabetes,” International Journal of Antimicrobial Agents, vol. 17, no. 4, pp. 287–292, 2001.
View at: Publisher Site | Google Scholar
A. Assefa, D. Asrat, Y. Woldeamanuel, A. Abdella, and T. Melesse, “Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa specialized hospital Addis Ababa, Ethiopia,” Ethiopian Medical Journal, vol. 46, no. 3, pp. 227–235, 2008.
View at: Google Scholar
T. Getaneh, A. Negesse, G. Dessie, M. Desta, and A. Tigabu, “Prevalence of urinary tract infection and its associated factors among pregnant women in Ethiopia: a systematic review and meta-analysis,” BioMed Research International, vol. 2021, Article ID 6551526, 12 pages, 2021.
View at: Publisher Site | Google Scholar
N. A. J. Al-Tulaibawi, “Prevalence and sensitivity of bacterial urinary tract infection among adult diabetic patients in Misan Province, Iraq,” Journal of Pure and Applied Microbiology, vol. 13, no. 2, pp. 847–853, 2019.
View at: Publisher Site | Google Scholar
A. K. Nisha, A. E. Etana, and H. Tesso, “Prevalence of asymptomatic bacteriuria during pregnancy in Adama city, Ethiopia,” International Journal of Microbiology and Immunology Research, vol. 3, no. 5, pp. 58–63, 2015.
View at: Google Scholar
A. Girma and A. Aemiro, “Prevalence and associated risk factors of intestinal parasites and enteric bacterial infections among selected region food handlers of Ethiopia during 2014–2022: a systematic review and meta-analysis,” The Scientific World Journal, vol. 2022, Article ID 7786036, 14 pages, 2022.
View at: Publisher Site | Google Scholar
A. Girma and D. Tamir, “Prevalence of bovine mastitis and its associated risk factors among dairy cows in Ethiopia during 2005–2022: a systematic review and meta-analysis,” Veterinary Medicine International, vol. 2022, Article ID 7775197, 19 pages, 2022.
View at: Publisher Site | Google Scholar
D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman, and P Group, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” Annals of Internal Medicine, vol. 151, no. 4, pp. 264–269, 2009.
View at: Publisher Site | Google Scholar
D. Atkins, M. Eccles, S. Flottorp et al., “Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches the GRADE working group,” BMC Health Services Research, vol. 4, no. 1, pp. 1–7, 2004.
View at: Publisher Site | Google Scholar
J. Higgins, S. Tompson, J. Deeks, and D. Altman, “Measuring inconsistency in meta-analyses,” BMJ, vol. 327, no. 7414, pp. 557–560, 2003.
View at: Publisher Site | Google Scholar
A. Alemu, F. Moges, Y. Shiferaw et al., “Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at University of Gondar Teaching Hospital, northwest Ethiopia,” BMC Research Notes, vol. 5, no. 1, pp. 1–7, 2012.
View at: Publisher Site | Google Scholar
G. Ferede, G. Yismaw, Y. Wondimeneh, and Z. Sisay, “The prevalence and antimicrobial susceptibility pattern of bacterial uropathogens isolated from pregnant women,” European Journal of Experimental Biology, vol. 2, no. 5, pp. 1497–1502, 2012.
View at: Google Scholar
G. Yismaw, D. Asrat, Y. Woldeamanuel, and C. G. Unakal, “Urinary tract infection: bacterial etiologies, drug resistance profile and associated risk factors in diabetic patients attending Gondar University Hospital, Gondar, Ethiopia,” European Journal of Experimental Biology, vol. 2, no. 4, pp. 889–898, 2012.
View at: Google Scholar
T. Emiru, G. Beyene, W. Tsegaye, and S. Melaku, “Associated risk factors of urinary tract infection among pregnant women at Felege Hiwot Referral Hospital, Bahir Dar, north west Ethiopia,” BMC Research Notes, vol. 6, no. 1, pp. 1–6, 2013.
View at: Publisher Site | Google Scholar
E. Tadesse, M. Teshome, Y. Merid, B. Kibret, and T. Shimelis, “Asymptomatic urinary tract infection among pregnant women attending the antenatal clinic of Hawassa Referral Hospital, southern Ethiopia,” BMC Research Notes, vol. 7, no. 1, p. 155, 2014.
View at: Publisher Site | Google Scholar
B. Derese, H. Kedir, Z. Teklemariam, F. Weldegebreal, and S. Balakrishnan, “Bacterial profile of urinary tract infection and antimicrobial susceptibility pattern among pregnant women attending at antenatal clinic in Dil Chora Referral Hospital, Dire Dawa, eastern Ethiopia,” Therapeutics and Clinical Risk Management, vol. 12, p. 251, 2016.
View at: Publisher Site | Google Scholar
F. Ahmed, E. Molla, and F. Eriso, “Prevalence and associated F infections among pregnant antenatal medical hospital, Borena zone,” Merit Research Journal of Medicine and Medical Sciences, vol. 4, no. 1, pp. 068–075, 2016.
View at: Google Scholar
Y. A. Gessese, D. L. Damessa, M. M. Amare et al., “Urinary pathogenic bacterial profile, antibiogram of isolates and associated risk factors among pregnant women in Ambo town, central Ethiopia: a cross-sectional study,” Antimicrobial Resistance & Infection Control, vol. 6, no. 1, pp. 1–10, 2017.
View at: Publisher Site | Google Scholar
D. Nigussie and A. Amsalu, “Prevalence of uropathogen and their antibiotic resistance pattern among diabetic patients,” Turkish Journal of Urology, vol. 43, no. 1, pp. 85–92, 2017.
View at: Publisher Site | Google Scholar
D. Regea, D. Alemayehu, and G. Mohammed, “Urinary tract infection: bacterial etiologies, drug resistance profile and associated risk factors among diabetic patients attending Nekemte Referral Hospital,” American Journal of Current Microbiology, vol. 5, no. 1, pp. 19–32, 2017.
View at: Google Scholar
D. Abate, G. Kabew, F. Urgessa, and D. Meaza, “Bacterial etiologies, antimicrobial susceptibility patterns and associated risk factors of urinary tract infection among diabetic patients attending diabetic clinics in Harar, eastern Ethiopia,” East African Journal of Health and Biomedical Sciences, vol. 1, no. 2, pp. 11–20, 2017.
View at: Google Scholar
A. D. Habteyohannes, D. Mekonnen, E. Abate, S. Tadesse, T. Birku, and F. Biadglegne, “Bacterial isolates and their current drug susceptibility profile from urine among asymptomatic pregnant women attending at a referral hospital, northwest Ethiopia; cross-sectional study,” Ethiopian Journal of Reproductive Health, vol. 10, no. 2, pp. 10–10, 2018.
View at: Google Scholar
I. E. Ali, T. Gebrecherkos, M. Gizachew, and M. A. Menberu, “Asymptomatic bacteriuria and antimicrobial susceptibility pattern of the isolates among pregnant women attending Dessie Referral Hospital, northeast Ethiopia: a hospital-based cross-sectional study,” Turkish Journal of Urology, vol. 44, no. 3, pp. 251–260, 2018.
View at: Publisher Site | Google Scholar
S. Taye, M. Getachew, Z. Desalegn, A. Biratu, and K. Mubashir, “Bacterial profile, antibiotic susceptibility pattern and associated factors among pregnant women with urinary tract infection in Goba and Sinana Woredas, Bale zone, southeast Ethiopia,” BMC Research Notes, vol. 11, no. 1, pp. 1–7, 2018.
View at: Publisher Site | Google Scholar
A. Negussie, G. Worku, and E. Beyene, “Bacterial identification and drug susceptibility pattern of urinary tract infection in pregnant women at Karamara Hospital Jigjiga, eastern Ethiopia,” African Journal of Bacteriology Research, vol. 10, no. 2, pp. 15–22, 2018.
View at: Google Scholar
S. Tadesse, T. Kahsay, G. Adhanom, G. Kahsu, H. Legese, and A. Derbie, “Prevalence, antimicrobial susceptibility profile and predictors of asymptomatic bacteriuria among pregnant women in Adigrat General Hospital, northern Ethiopia,” BMC Research Notes, vol. 11, no. 1, pp. 1–6, 2018.
View at: Publisher Site | Google Scholar
B. Kumera, T. Anteneh, and K. Aragaw, “Asymptomatic bacteriuria in relation to diabetic women attending Hawassa University Referral Hospital, southern Ethiopia,” European Journal of Experimental Biology, vol. 8, no. 1, p. 5, 2018.
View at: Publisher Site | Google Scholar
T. Gutema, F. Weldegebreal, D. Marami, and Z. Teklemariam, “Prevalence, antimicrobial susceptibility pattern, and associated factors of urinary tract infections among adult diabetic patients at Metu Karl Heinz Referral Hospital, southwest Ethiopia,” International Journal of Microbiology, vol. 2018, Article ID 7591259, 7 pages, 2018.
View at: Publisher Site | Google Scholar
M. Mama, A. Manilal, T. Gezmu, A. Kidanewold, F. Gosa, and A. Gebresilasie, “Prevalence and associated factors of urinary tract infections among diabetic patients in Arba Minch Hospital, Arba Minch province, south Ethiopia,” Turkish Journal of Urology, vol. 45, no. 1, pp. 56–62, 2019.
View at: Publisher Site | Google Scholar
H. K. Woldemariam, D. A. Geleta, K. D. Tulu et al., “Common uropathogens and their antibiotic susceptibility pattern among diabetic patients,” BMC Infectious Diseases, vol. 19, no. 1, pp. 1–10, 2019.
View at: Publisher Site | Google Scholar
A. Tula, A. Mikru, T. Alemayehu, and B. Dobo, “Bacterial profile and antibiotic susceptibility pattern of urinary tract infection among pregnant women attending antenatal care at a tertiary care hospital in southern Ethiopia,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 2020, Article ID 5321276, 9 pages, 2020.
View at: Publisher Site | Google Scholar
A. Kumalo and M. Tadesse, “Asymptomatic bacteriuria and their antimicrobial susceptibility pattern among pregnant women attending antenatal clinics at Mizan Aman town, southwestern Ethiopia,” Biomedical Science, vol. 6, no. 4, pp. 56–62, 2020.
View at: Publisher Site | Google Scholar
D. Abate, D. Marami, and S. Letta, “Prevalence, antimicrobial susceptibility pattern, and associated factors of urinary tract infections among pregnant and nonpregnant women at public health facilities, Harar, eastern Ethiopia: a comparative cross-sectional study,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 2020, Article ID 9356865, 9 pages, 2020.
View at: Publisher Site | Google Scholar
M. Edae, Z. Teklemariam, F. Weldegebreal, and D. Abate, “Asymptomatic bacteriuria among pregnant women attending antenatal care at Hiwot Fana Specialized University Hospital, Harar, eastern Ethiopia: magnitude, associated factors, and antimicrobial susceptibility pattern,” International Journal of Microbiology, vol. 2020, Article ID 1763931, 8 pages, 2020.
View at: Publisher Site | Google Scholar
Y. A. Wabe, D. Y. Reda, E. T. Abreham, D. B. Gobene, and M. M. Ali, “Prevalence of asymptomatic bacteriuria, associated factors and antimicrobial susceptibility profile of bacteria among pregnant women attending Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia,” Therapeutics and Clinical Risk Management, vol. 16, pp. 923–932, 2020.
View at: Publisher Site | Google Scholar
M. A. Belete, “Bacterial profile and ESBL screening of urinary tract infection among asymptomatic and symptomatic pregnant women attending antenatal care of northeastern Ethiopia region,” Infection and Drug Resistance, vol. 13, pp. 2579–2592, 2020.
View at: Publisher Site | Google Scholar
S. Biset, F. Moges, D. Endalamaw, and S. Eshetie, “Multi-drug resistant and extended-spectrum β-lactamases producing bacterial uropathogens among pregnant women in northwest Ethiopia,” Annals of Clinical Microbiology and Antimicrobials, vol. 19, no. 1, pp. 1–9, 2020.
View at: Publisher Site | Google Scholar
M. Alemu, M. A. Belete, S. Gebreselassie, A. Belay, and D. Gebretsadik, “Bacterial profiles and their associated factors of urinary tract infection and detection of extended spectrum beta-lactamase producing gram-negative uropathogens among patients with diabetes mellitus at Dessie Referral Hospital, northeastern Ethiopia,” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 13, pp. 2935–2948, 2020.
View at: Publisher Site | Google Scholar
A. Mohammed, G. Beyene, and L. Teshager, “Urinary pathogenic bacterial profile, antibiogram of isolates and associated risk factors among diabetic patients in Hawassa town, southern Ethiopia: a cross-sectional study,” Urology & Nephrology Open Access Journal, vol. 8, no. 4, pp. 84–91, 2020.
View at: Publisher Site | Google Scholar
D. Abu, T. Abula, T. Zewdu, M. Berhanu, and T. Sahilu, “Asymptomatic bacteriuria, antimicrobial susceptibility pattern and associated risk factors among pregnant women attending antenatal care in Assosa General Hospital, Western Ethiopia,” BMC Microbiology, vol. 21, no. 1, pp. 1–8, 2021.
View at: Publisher Site | Google Scholar
K. Bizuwork, H. Alemayehu, G. Medhin, W. Amogne, and T. Eguale, “Asymptomatic bacteriuria among pregnant women in Addis Ababa, Ethiopia: prevalence, causal agents, and their antimicrobial susceptibility,” International Journal of Microbiology, vol. 2021, Article ID 8418043, 8 pages, 2021.
View at: Publisher Site | Google Scholar
W. Zebene, D. Dessalegn, A. Aseffa, Y. Yitagesu, H. Yussuf, and K. Desta, “Urinary tract infection, drug resistance profile and fetal outcomes among pregnant women in selected health facilites of Addis Ababa, Ethiopia: a cross-sectional study design,” Journal of Gynecology & Reproductive Medicine, vol. 5, no. 1, 2021.
View at: Google Scholar
A. W. Ejerssa, D. A. Gadisa, and T. A. Orjino, “Prevalence of bacterial uropathogens and their antimicrobial susceptibility patterns among pregnant women in eastern Ethiopia: hospital-based cross-sectional study,” BMC Women's Health, vol. 21, no. 1, p. 291, 2021.
View at: Publisher Site | Google Scholar
E. Nigussie, M. Mitiku, A. Tasew et al., “Drug susceptibility pattern and associated factors of bacteria isolated from urinary tract infection among pregnant women attending antenatal care in Teaching Referral Hospital, southeast Ethiopia,” Journal of Gynecology & Reproductive Medicine, vol. 5, no. 2, pp. 1–3, 2021.
View at: Publisher Site | Google Scholar
G. Y. Worku, Y. B. Alamneh, and W. E. Abegaz, “Prevalence of bacterial urinary tract infection and antimicrobial susceptibility patterns among diabetes mellitus patients attending Zewditu Memorial Hospital, Addis Ababa, Ethiopia,” Infection and Drug Resistance, vol. 14, pp. 1441–1454, 2021.
View at: Publisher Site | Google Scholar
B. Walelgn, M. Abdu, and P. Kumar, “The occurrence of urinary tract infection and determinant factors among diabetic patients at Dessie Referral Hospital, South Wollo, northeast Ethiopia,” SAGE Open Medicine, vol. 9, 2021.
View at: Publisher Site | Google Scholar
O. Oumer, Y. Metaferia, and D. Gebretsadik, “Bacterial uropathogens, their associated factors, and antimicrobial susceptibility pattern among adult diabetic patients in two health centers at Kombolcha town, northeastern Ethiopia,” SAGE Open Medicine, vol. 10, 2022.
View at: Publisher Site | Google Scholar
S. Worku, A. Girum, A. Birhan, and A. Alemu, Urinary Tract Infection: Antibiotic Resistance Profiles of Bacterial Etiologies and Associated Risk Factors in Diabetic Patients Attending Debre Tabor Hospital, Northwest Ethiopia, 2022, http://etd.hu.edu.et/handle/123456789/2838.
D. Assegu, Prevalence of Extended-Spectrum Beta-Lactamase Producing Bacteria Isolated from Urine of Diabetes Patients, their Drug Resistance Profile and Associated Factors at Hawassa University Comprehensive Specialized Hospital Sidama, Hawassa, Ethiopia, 2022, http://etd.hu.edu.et/handle/123456789/2838.
K. Kalinderi, D. Delkos, M. Kalinderis, A. Athanasiadis, and I. Kalogiannidis, “Urinary tract infection during pregnancy: current concepts on a common multifaceted problem,” Journal of Obstetrics and Gynaecology, vol. 38, no. 4, pp. 448–453, 2018.
View at: Publisher Site | Google Scholar
B. S. Ooi, B. T. Chen, and M. Yu, “Prevalence and site of bacteriuria in diabetes mellitus,” Postgraduate Medical Journal, vol. 50, no. 586, pp. 497–499, 1974.
View at: Publisher Site | Google Scholar
U. Chukwuocha, C. Emerole, T. Njokuobi, and I. Nwawume, “Urinary tract infections (UTIs) associated with diabetic patients in the Federal Medical Center Owerri, Nigeria,” Global Advanced Research Journal of Microbiology, vol. 1, no. 5, pp. 62–66, 2012.
View at: Google Scholar
H. Z. Hamdan, E. Kubbara, A. M. Adam, O. S. Hassan, S. O. Suliman, and I. Adam, “Urinary tract infections and antimicrobial sensitivity among diabetic patients at Khartoum, Sudan,” Annals of Clinical Microbiology and Antimicrobials, vol. 14, no. 1, pp. 1–6, 2015.
View at: Publisher Site | Google Scholar
G. Beyene and W. Tsegaye, “Bacterial uropathogens in urinary tract infection and antibiotic susceptibility pattern in Jimma University Specialized Hospital, southwest Ethiopia,” Ethiopian Journal of Health Sciences, vol. 21, no. 2, pp. 141–146, 2011.
View at: Publisher Site | Google Scholar
L. Ampaire, A. Butoto, P. Orikiriza, O. Muhwezi, and A. Papazafiropoulou, “Bacterial and drug susceptibility profiles of urinary tract infection in diabetes mellitus patients at Mbarara Regional Referral Hospital, Uganda,” British Microbiology Research Journal, vol. 9, no. 4, pp. 1–5, 2015.
View at: Publisher Site | Google Scholar
A. Derbie, D. Hailu, D. Mekonnen, B. Abera, and G. Yitayew, “Antibiogram profile of uropathogens isolated at Bahir Dar Regional Health Research Laboratory Centre, northwest Ethiopia,” The Pan African Medical Journal, vol. 26, p. 134, 2017.
View at: Publisher Site | Google Scholar
C. Chiu and C. F. Moss, “The role of the external ear in vertical sound localization in the free flying bat, Eptesicus fuscus,” The Journal of the Acoustical Society of America, vol. 121, no. 4, pp. 2227–2235, 2007.
View at: Publisher Site | Google Scholar
T. M. J. Taher, F. T. R. Sarray, A. S. Shwekh, T. K. Mareedh, and H. F. Ghazi, “Bacterial causes of urinary tract infection among diabetic and non-diabetic patients in Al-Kut City, Iraq,” Borneo Epidemiology Journal, vol. 2, no. 1, 2021.
View at: Publisher Site | Google Scholar
W. D. Seifu and A. D. Gebissa, “Prevalence and antibiotic susceptibility of Uropathogens from cases of urinary tract infections (UTI) in Shashemene Referral Hospital, Ethiopia,” BMC Infectious Diseases, vol. 18, no. 1, pp. 1–9, 2018.
View at: Publisher Site | Google Scholar
M. Odoki, J. Bazira, M. Moazam, and E. Agwu, “Health-point survey of bacteria urinary tract infections among suspected diabetic patients attending clinics in Bushenyi district of Uganda,” Special Bacteria Pathogens Journal (SBPJ), vol. 9, pp. 11–20, 2015.
View at: Google Scholar
M. Sewify, S. Nair, S. Warsame et al., “Prevalence of urinary tract infection and antimicrobial susceptibility among diabetic patients with controlled and uncontrolled glycemia in Kuwait,” Journal of Diabetes Research, vol. 2016, Article ID 6573215, 7 pages, 2016.
View at: Publisher Site | Google Scholar
V. Sharma, V. Gupta, and M. Mittal, “Prevalence of uropathogens in diabetic patients and their antimicrobial susceptibility pattern,” National Journal of Laboratory Medicine, vol. 1, no. 1, pp. 26–28, 2012.
View at: Google Scholar
K. U. Zubair, A. H. Shah, A. Fawwad, R. Sabir, and A. Butt, “Frequency of urinary tract infection and antibiotic sensitivity of uropathogens in patients with diabetes,” Pakistan Journal of Medical Sciences, vol. 35, no. 6, pp. 1664–1668, 2019.
View at: Publisher Site | Google Scholar
M. M. G.-A. El-Nagar, A. E.-D. Abd El-Salam, H. M. Gabr, and E. E.-D. M. Abd El, “Prevalence of urinary tract infection in Damietta diabetic patients,” Menoufia Medical Journal, vol. 28, no. 2, p. 559, 2015.
View at: Publisher Site | Google Scholar
P. Kumar Jha, R. Baral, and B. Khanal, “Prevalence of uropathogens in diabetic patients and their susceptibility pattern at a tertiary care center in Nepal-a retrospective study,” International Journal of Biomedical Laboratory Science, vol. 3, pp. 29–34, 2014.
View at: Google Scholar
E. F. Lyamuya, S. J. Moyo, E. V. Komba, and M. Haule, “Prevalence, antimicrobial resistance and associated risk factors for bacteriuria in diabetic women in Dar es Salaam, Tanzania,” African Journal of Microbiology Research, vol. 5, no. 6, pp. 683–689, 2011.
View at: Google Scholar
O. Samuel, A. Mathew, D. Agboola, A. Mopelola, O. Joshua, and A. Tosin, “Asymptomatic urinary tract infection in diabetic patients in Ago–Iwoye, Ogun State, Nigeria,” Journal of American Science, vol. 10, no. 4, pp. 72–78, 2014.
View at: Google Scholar
B. Chaudhary, C. Charu, and S. Shukla, “Bacteriology of urinary tract infection and antibiotic susceptibility pattern among diabetic patients,” International Journal of Bioassays, vol. 3, no. 8, pp. 3224–3227, 2014.
View at: Google Scholar
A.-H. Al-Qaseer, B. H. Abdul-wahab, and O. K. Abbas, “Bacteriological finding of urinary tract infection in diabetic patients,” International Journal, vol. 2, no. 10, pp. 274–279, 2014.
View at: Google Scholar
K. Yadav and S. Prakash, “Antimicrobial resistance pattern of uropathogens causing urinary tract infection (UTI) among diabetics,” Biomedical Research International, vol. 1, pp. 7–15, 2016.
View at: Google Scholar
M. Ijaz, S. A. Ali, S. M. Khan, M. Hassan, and I. H. Bangash, “Urinary tract infection in diabetic patients; causative bacteria and antibiotic sensitivity,” Journal of Medical Sciences, vol. 22, no. 3, pp. 110–114, 2014.
View at: Google Scholar
M. S. H. Akash, K. Rehman, F. Fiayyaz, S. Sabir, and M. Khurshid, “Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies,” Archives of Microbiology, vol. 202, no. 5, pp. 953–965, 2020.
View at: Publisher Site | Google Scholar
B. Vaishnav, A. Bamanikar, P. Maske, V. S. Rathore, V. Khemka, and D. Sharma, “Study of clinico-pathological and bacteriological profile of urinary tract infections in geriatric patients with type 2 diabetes mellitus,” International Journal of Current Research and Review, vol. 7, no. 21, p. 13, 2015.
View at: Google Scholar
K. D. Tegegne, G. B. Wagaw, N. A. Gebeyehu, L. T. Yirdaw, N. E. Shewangashaw, and M. W. Kassaw, “Prevalence of urinary tract infections and risk factors among diabetic patients in Ethiopia, a systematic review and meta-analysis,” PLoS One, vol. 18, no. 1, article e0278028, 2023.
View at: Publisher Site | Google Scholar
Z. Hamdan, A. H. M. Ziad, S. K. Ali, and I. Adam, “Epidemiology of urinary tract infections and antibiotics sensitivity among pregnant women at Khartoum North Hospital,” Annals of Clinical Microbiology and Antimicrobials, vol. 10, no. 1, p. 5, 2011.
View at: Publisher Site | Google Scholar
P. Wamalwa, J. Omolo, and A. Makokha, “Prevalence and risk factors for urinary tract infections among pregnant women,” Prime Journal of Social Science, vol. 2, no. 12, pp. 524–531, 2013.
View at: Google Scholar
A. Masinde, B. Gumodoka, A. Kilonzo, and S. Mshana, “Prevalence of urinary tract infection among pregnant women at Bugando Medical Centre, Mwanza, Tanzania,” Tanzania Journal of Health Research, vol. 11, no. 3, 2009.
View at: Publisher Site | Google Scholar
T. Demilie, G. Beyene, S. Melaku, and W. Tsegaye, “Urinary bacterial profile and antibiotic susceptibility pattern among pregnant women in north west Ethiopia,” Ethiopian Journal of Health Sciences, vol. 22, no. 2, pp. 121–128, 2012.
View at: Google Scholar
M. Tamalli, S. Bioprabhu, and M. Alghazal, “Urinary tract infection during pregnancy at Al-Khoms, Libya,” International Journal of Medicine and Medical Sciences, vol. 3, no. 5, pp. 455–459, 2013.
View at: Google Scholar
N. A. Al-Mamoryi and A. S. Al-Salman, “Prevalence of symptomatic urinary tract infections and asymptomatic bacteriuria in Iraqi pregnant women of Babylon governorate,” Medical Journal of Babylon, vol. 16, no. 1, pp. 5–12, 2019.
View at: Publisher Site | Google Scholar
A. Turay, S. Eke, P. Oleghe, and M. Ozekhome, “The prevalence of urinary tract infections among pregnant women attending antenatal clinic at Ujoelen Primary Health Care Centre, Ekpoma, Edo state, Nigeria,” International Journal of Basic, Applied and Innovative Research, vol. 3, no. 3, pp. 86–94, 2014.
View at: Google Scholar
S. Worku, A. Derbie, M. A. Sinishaw, Y. Adem, and F. Biadglegne, “Prevalence of bacteriuria and antimicrobial susceptibility patterns among diabetic and nondiabetic patients attending at Debre Tabor Hospital, northwest Ethiopia,” International Journal of Microbiology, vol. 2017, Article ID 5809494, 8 pages, 2017.
View at: Publisher Site | Google Scholar
T. Chiţă, M. Licker, A. Sima et al., “Prevalence of urinary tract infections in diabetic patients,” Romanian Journal of Diabetes Nutrition and Metabolic Diseases, vol. 20, no. 2, pp. 99–105, 2013.
View at: Publisher Site | Google Scholar
K. A. Al-Rubeaan, O. Moharram, D. Al-Naqeb, A. Hassan, and M. Rafiullah, “Prevalence of urinary tract infection and risk factors among Saudi patients with diabetes,” World Journal of Urology, vol. 31, no. 3, pp. 573–578, 2013.
View at: Publisher Site | Google Scholar
J. S. Brown, H. Wessells, M. B. Chancellor et al., “Urologic complications of diabetes,” Diabetes Care, vol. 28, no. 1, pp. 177–185, 2005.
View at: Publisher Site | Google Scholar
P. Vignesh, T. Gopinath, and D. Sriram, “Urinary tract infection among type 2 diabetic patients admitted in a multispecialty hospital in South Chennai, Tamil Nadu,” International Journal Of Community Medicine And Public Health, vol. 6, no. 3, p. 1295, 2019.
View at: Publisher Site | Google Scholar
H. M. Shaheen, T. M. Farahat, and N. A. E.-H. Hammad, “Prevalence of urinary tract infection among pregnant women and possible risk factors,” Menoufia Medical Journal, vol. 29, no. 4, p. 1055, 2016.
View at: Google Scholar
G. Haider, N. Zehra, A. A. Munir, and A. Haider, “Risk factors of urinary tract infection in pregnancy,” The Journal of the Pakistan Medical Association, vol. 60, no. 3, pp. 213–216, 2010.
View at: Google Scholar
S. E. Geerlings, R. P. Stolk, M. J. Camps et al., “Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes mellitus women asymptomatic bacteriuria Utrecht study group,” Diabetes Care, vol. 23, no. 6, pp. 744–749, 2000.
View at: Publisher Site | Google Scholar
H. S. Faidah, A. M. Ashshi, G. A. Abou El-Ella, A. K. Al-Ghamdi, and A. M. Mohamed, “Urinary tract infections among pregnant women in Makkah, Saudi Arabia,” Biomedical And Pharmacology Journal, vol. 6, no. 1, pp. 1–7, 2013.
View at: Publisher Site | Google Scholar
O. Storme, J. Tirán Saucedo, A. Garcia-Mora, M. Dehesa-Dávila, and K. G. Naber, “Risk factors and predisposing conditions for urinary tract infection,” Therapeutic Advances in Urology, vol. 11, 2019.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2023 Abayeneh Girma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1028

Downloads

694

Citations